Home » Stocks » RMED

Ra Medical Systems, Inc. (RMED)

Stock Price: $3.65 USD -0.16 (-4.20%)
Updated Apr 19, 2021 12:03 PM EDT - Market open
Market Cap 12.42M
Revenue (ttm) 4.41M
Net Income (ttm) -36.05M
Shares Out 1.70M
EPS (ttm) -21.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 19
Last Price $3.65
Previous Close $3.81
Change ($) -0.16
Change (%) -4.20%
Day's Open 3.77
Day's Range 3.61 - 3.80
Day's Volume 62,265
52-Week Range 3.61 - 31.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

LOS ANGELES, April 14, 2021 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, announces that on March 24, 2021, the Honorable Larry Alan Burns of the ...

4 days ago - PRNewsWire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...

1 month ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #RothConference--Ra Medical Systems to participate in the Virtual 33rd Annual Roth Conference and Maxim Emerging Growth Conference in March.

1 month ago - Business Wire

Wall Street recommends purchasing shares of Ra Medical Systems Inc (RMED) and Baudax Bio Inc (NASDAQ:BXRX), which sounds quite unexpected since these two equities have shown poor performance over the pr...

Other stocks mentioned: BXRX
1 month ago - GuruFocus

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2020 fourth quarter and full year financial results and provide a business update after market clos...

1 month ago - Business Wire

Ra Medical Systems, Inc. (RMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...

1 month ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases...

2 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...

2 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...

3 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) today announced it has entered into a settlement agreement that resolves civil False Claims Act claims asserted by the U...

3 months ago - Business Wire

The short term investor may want to consider this trio of companies

Other stocks mentioned: CLBS, JT
3 months ago - GuruFocus

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems moves to the NYSE American.

4 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces the availability of its webcast event, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, discussing t...

4 months ago - Business Wire

LOS ANGELES, Dec. 7, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc. ("Ra Medical" or the...

4 months ago - PRNewsWire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) is hosting a webcast, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, featuring Theodore J. Daly, MD, FAAD, F...

4 months ago - Business Wire

In this article we will check out the progression of hedge fund sentiment towards Ra Medical Systems, Inc. (NYSE:RMED) and determine whether it is a good investment right now. We at Insider Monkey like ...

4 months ago - Insider Monkey

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, annou...

4 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announc...

5 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announced today that its Board of Directors has approved a 1-for-25 reverse stock split of the Company's common stock, which will...

5 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, annou...

5 months ago - Business Wire

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, report...

5 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical System to host webcast discussing the role of excimer lasers in the treatment of psoriasis during the pandemic

5 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems Hosts Summit with Vascular Physicians to Monitor Progress on Next-Generation DABRA Catheter Design

5 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report third quarter 2020 financial results and provide a business update after market close on Thursday, ...

5 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medi...

5 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announc...

6 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.

7 months ago - Business Wire

Ra Medical Systems, Inc. (RMED) CEO Jonathan McGuire on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Shares of Ra Medical Systems (NYSE:RMED) decreased 9.56% in after-market trading after the company reported Q2 results.

8 months ago - Benzinga

Ra Medical Systems, Inc. (RMED) delivered earnings and revenue surprises of -152.94% and 125.00%, respectively, for the quarter ended June 2020.

8 months ago - Zacks Investment Research

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.

8 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.

8 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.

8 months ago - Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.

8 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical” or the “C...

9 months ago - Business Wire

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investiga...

9 months ago - Business Wire

NEW ORLEANS, May 22, 2020 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced ...

10 months ago - PRNewsWire

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Ra Medical Systems Inc (RMED) delivered earnings and revenue surprises of -166.67% and -9.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

These five stocks are poised to grow with the guidelines laid out to reopen the economy, as coronavirus pandemic dissipates.

Other stocks mentioned: AWR, BGCP, ELOX, SHSP
11 months ago - Zacks Investment Research

Ra Medical Systems' (RMED) Management on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Ra Medical Systems' (RMED) CEO Dean Irwin on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Ra Medical Systems, Inc. (RMED) CEO Dean Irwin on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About RMED

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser d... [Read more...]

Industry
Medical Devices
IPO Date
Aug 30, 2018
Stock Exchange
NYSEAMERICAN
Ticker Symbol
RMED
Full Company Profile

Financial Performance

In 2020, RMED's revenue was $4.41 million, a decrease of -38.81% compared to the previous year's $7.20 million. Losses were -$36.05 million, -36.72% less than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for RMED stock is "Buy." The 12-month stock price forecast is 25.00, which is an increase of 584.93% from the latest price.

Price Target
$25.00
(584.93% upside)
Analyst Consensus: Buy